Greetings from Oviya MedSafe! While we are always glad to reconnect to you through our newsletter periodically, this edition is more special for us as we make a couple of important announcements which would define the future growth of Oviya MedSafe to a leading full-service global Pharmacovigilance Consulting and Services Company.
The global delivery center of Oviya MedSafe Pvt Ltd is based out of Coimbatore – a growing IT hub and established Healthcare city in India. A brief yet descriptive professionally made video on the business potential of Coimbatore city can be viewed at http://www.youtube.com/
We are proud to announce that the internationally renowned Ma Foi group, through its group company Ma Foi Strategic Consultants Pvt Ltd (www.mafoistrategy.com) has invested to the tune of 17.5% of the total equity in Oviya MedSafe Pvt Ltd. Ma Foi will provide strategic and operational support for Oviya MedSafe on an ongoing basis. Mr K Pandiarajan, Founder of the Ma Foi group and Managing Director of Ma Foi Strategic Consultants Pvt Ltd has joined the board of directors of Oviya MedSafe Pvt Ltd.
Oviya MedSafe’s key services would include:
– Individual Case Safety Reports & Aggregate Reports – The Complete Life Cycle
– Narrative Writing & Review for Clinical Trial and Spontaneous Cases
– Post-marketing Surveillance Studies – Planning and Execution
– Turnkey Consulting Projects in Pharmacovigilance
If you think we can help you in any other function, do let us know. We shall be glad to discuss how we could work together.
For more information, please visit www.oviyamedsafe.com or send an e-mail to email@example.com.
Follow us on:
Dr J Vijay Venkatraman.
Founder & CEO,
Oviya MedSafe Pvt. Ltd.